Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action
- 18 March 1999
- journal article
- review article
- Published by Elsevier
- Vol. 58 (1) , 31-59
- https://doi.org/10.1016/s0301-0082(98)00075-6
Abstract
No abstract availableKeywords
This publication has 181 references indexed in Scilit:
- In vivo administration of valproate reduces the nerve terminal (synaptosomal) activity of GABA aminotransferase in discrete brain areas of ratsNeuroscience Letters, 1993
- On the development of alternative antiepileptic drugsThe Science of Nature, 1991
- Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neuronsNeuroscience Letters, 1990
- γ-Aminobutyric acid-ergic analgesia: Implications for γ-aminobutyric acid-ergic therapy for drug addictionsDrug and Alcohol Dependence, 1984
- Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate contentLife Sciences, 1983
- The Toxicity of Metabolites of Sodium Valproate in Cultured HepatocytesThe Journal of Clinical Pharmacology, 1983
- Central actions of valproic acid in man and in experimental models of epilepsyLife Sciences, 1981
- Plasma GABA levels in neurological patients under treatment with valproic acidLife Sciences, 1981
- The mechanism of action of sodium valproateGeneral Pharmacology: The Vascular System, 1981
- Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicucullineLife Sciences, 1977